Literature DB >> 4856629

Structure-antitumor activity relationships among quinone derivatives.

J S Driscoll, G F Hazard, H B Wood, A Goldin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4856629

Source DB:  PubMed          Journal:  Cancer Chemother Rep 2        ISSN: 0069-0120


× No keyword cloud information.
  19 in total

1.  Inhibition of adriamycin cardiotoxicity by acetyldaunomycin.

Authors:  G Zbinden
Journal:  Experientia       Date:  1975-09-15

Review 2.  Unconventional therapies for cancer: 1. Essiac. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-04-07       Impact factor: 8.262

3.  High dose AZQ in renal cancer. A Southwest Oncology Group phase II study.

Authors:  R L Stephens; R Kirby; E D Crawford; R Bukowski; S E Rivkin; R M O'Bryan
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

4.  Microbial transformations of natural antitumor agents: conversion of lapachol to dehydro-alpha-lapachone by Curvularia lunata.

Authors:  S Otten; J P Rosazza
Journal:  Appl Environ Microbiol       Date:  1979-08       Impact factor: 4.792

5.  Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma.

Authors:  J Maral; M Poisson; B F Pertuiset; P Mashaly; M Weil; C Jacquillat; A J Grillo-Lopez
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

Review 6.  Diaziquone (AZQ).

Authors:  J F Bender; A J Grillo-Lopez; J G Posada
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

7.  Response variability of human brain tumors to AZQ in tissue culture.

Authors:  P L Kornblith; L Rosa; J D Bona; J A Edwards; N Matuzic; A Hirschfeld; C Hawkins
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

Review 8.  Are reduced quinones necessarily involved in the antitumour activity of quinone drugs?

Authors:  J Butler; B M Hoey
Journal:  Br J Cancer Suppl       Date:  1987-06

9.  Stability of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZQ; NSC 224070) in aqueous solutions by high-performance liquid chromatography.

Authors:  A G Bosanquet; S B McLoughlin
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

10.  Mutagenicity of quinones: pathways of metabolic activation and detoxification.

Authors:  P L Chesis; D E Levin; M T Smith; L Ernster; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.